Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fivespan Partners is a life sciences venture creation firm dedicated to building and launching innovative biotechnology companies. Founded by Douglas Fambrough, the former CEO of Dicerna Pharmaceuticals, the firm leverages deep industry expertise to translate breakthrough scientific discoveries into therapeutic platforms. Fivespan focuses on identifying unique biological insights and assembling the necessary resources, including capital and management talent, to advance programs from concept to clinical validation. The firm's approach emphasizes the development of novel modalities to address complex diseases with high unmet needs. Operating primarily in stealth, Fivespan acts as both an investor and an operator during the early stages of company formation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fivespan Partners.